Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125789713 | 12578971 | 3 | F | 20160504 | 20160913 | 20160721 | 20160916 | EXP | PHHY2016CA045639 | NOVARTIS | 53.57 | YR | M | Y | 0.00000 | 20160916 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125789713 | 12578971 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | QD | |||||||
| 125789713 | 12578971 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | QD | |||||||
| 125789713 | 12578971 | 3 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, BID | 21588 | 400 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125789713 | 12578971 | 1 | Gastrointestinal stromal tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125789713 | 12578971 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125789713 | 12578971 | Asthenia | |
| 125789713 | 12578971 | Decreased appetite | |
| 125789713 | 12578971 | Dyspnoea | |
| 125789713 | 12578971 | Feeling abnormal | |
| 125789713 | 12578971 | Gastrointestinal disorder | |
| 125789713 | 12578971 | Haemoglobin decreased | |
| 125789713 | 12578971 | Headache | |
| 125789713 | 12578971 | Hepatomegaly | |
| 125789713 | 12578971 | Hyperhidrosis | |
| 125789713 | 12578971 | Hypopnoea | |
| 125789713 | 12578971 | Migraine | |
| 125789713 | 12578971 | Musculoskeletal stiffness | |
| 125789713 | 12578971 | Nephrolithiasis | |
| 125789713 | 12578971 | Oropharyngeal pain | |
| 125789713 | 12578971 | Pain | |
| 125789713 | 12578971 | Pyrexia | |
| 125789713 | 12578971 | Viral test positive | |
| 125789713 | 12578971 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125789713 | 12578971 | 1 | 20160304 | 0 |